BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2627112)

  • 1. Gangliosides in human urothelial cell lines of different transformed phenotypes: the effect of v-raf-oncogene transfection.
    Ugorski M; Dus D; Skouv J; Påhlsson P; Radzikowski C
    Anticancer Res; 1989; 9(6):1583-6. PubMed ID: 2627112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional identification and molecular cloning of a rat gene mediating growth inhibition and programmed cell death in normal and transformed rat cell lines.
    Schwarte-Waldhoff I; Martin W; Willecke K; Schäfer R
    Oncogene; 1994 Mar; 9(3):899-909. PubMed ID: 8108134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in glycoconjugates related to the transformation grade of human uroepithelial cell lines.
    Ugorski M; Duś D
    Arch Immunol Ther Exp (Warsz); 1995; 43(3-4):161-6. PubMed ID: 8744689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic modulation of keratins, vimentin, and alpha-fetoprotein in cultured rat liver epithelial cells after chemical, oncogene, and spontaneous transformation.
    Bisgaard HC; Ton PT; Nagy P; Thorgeirsson SS
    J Cell Physiol; 1994 Jun; 159(3):485-94. PubMed ID: 7514612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
    Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
    Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peanut agglutinin (PNA) binding glycoproteins on human urothelial cell lines of different grades of transformation.
    Duś D; Ugorski M; Gorczyca W; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1995; 43(5-6):273-80. PubMed ID: 8744647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant.
    Rapp UR; Troppmair J; Beck T; Birrer MJ
    Oncogene; 1994 Dec; 9(12):3493-8. PubMed ID: 7970709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neosynthesis of neolacto- and novel ganglio-series gangliosides in a rat fibroblastic cell line brought about by transfection with the v-fes oncogene-containing Gardner-Arnstein strain feline sarcoma virus-DNA.
    Nakaishi H; Sanai Y; Shibuya M; Iwamori M; Nagai Y
    Cancer Res; 1988 Apr; 48(7):1753-8. PubMed ID: 3349454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colony stimulating factor-1 induced growth stimulation of v-fms transformed fibroblasts.
    Lyman SD; Park L; Rohrschneider LR
    Oncogene; 1988 Oct; 3(4):391-5. PubMed ID: 2856249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homologous and heterologous gap-junctional intercellular communication in v-raf-, v-myc-, and v-raf/v-myc-transduced rat liver epithelial cell lines.
    Kalimi GH; Hampton LL; Trosko JE; Thorgeirsson SS; Huggett AC
    Mol Carcinog; 1992; 5(4):301-10. PubMed ID: 1379816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The v-rel oncogene encodes a cell-specific transcriptional activator of certain promoters.
    Gélinas C; Temin HM
    Oncogene; 1988 Oct; 3(4):349-55. PubMed ID: 2856247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. v-erbA cooperates with bFGF in neuroretina cell transformation.
    Garrido C; Li RP; Samarut J; Gospodarowicz D; Saule S
    Virology; 1993 Feb; 192(2):578-86. PubMed ID: 7678474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. v-Ras and v-Raf block differentiation of transformable C3H10T1/2-derived preadipocytes at lower levels than required for neoplastic transformation.
    Raptis L; Brownell HL; Lu Y; Preston T; Narsimhan RP; Anderson S; Schaefer E; Haliotis T
    Exp Cell Res; 1997 Aug; 235(1):188-97. PubMed ID: 9281368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous metastasis of rat liver epithelial cells transformed with v-raf and v-raf/v-myc: association with different phenotypic properties.
    Bisgaard HC; Mackay AR; Gomez DE; Ton PT; Thorgeirsson SS; Thorgeirsson UP
    Invasion Metastasis; 1997; 17(5):240-50. PubMed ID: 9876218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of normal and transforming mil(raf) proteins: effect of 5'-truncation on phosphorylation in vivo or in vitro.
    Patschinsky T; Bister K
    Oncogene; 1988 Oct; 3(4):357-64. PubMed ID: 3274084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
    Topol LZ; Marx M; Calothy G; Blair DG
    Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth requirements and growth pattern of human urothelial cell lines of different grades of transformation.
    Christensen B; Kieler J; Bem W
    Anticancer Res; 1987; 7(3 Pt B):481-90. PubMed ID: 3631908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of a mammary epithelial cell line by the v-raf and v-mos oncogenes.
    Scully JL; Edwards PA
    Int J Cancer; 1991 Apr; 48(1):128-35. PubMed ID: 1826898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus.
    Blasi E; Radzioch D; Merletti L; Varesio L
    Cancer Biochem Biophys; 1989 Oct; 10(4):303-17. PubMed ID: 2695237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.